BioSig Technologies, Inc. (OTCQB:BSGM) Development Updates Regarding Vicromax Conference Call April 7, 2020 11:00 AM ET Company Participants Andy Ballou - VP, IR Ken Londoner - Chairman and CEO, BioSig Technologies Nick Spring - CEO, ViralClear Pharmaceuticals Steve King - COO, ViralClear pharmaceuticals Dr. Jerry Zeldis - Founder and Executive Chair, ViralClear Pharmaceuticals Dr. Andrew Badley - Physician Scientist, Mayo Clinic Conference Call Participants Gary Zwetchkenbaum - Plum Tree Consulting Hugh Ma ...